14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
GLAD vs CCAP: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, Gladstone Capital Corp (GLAD) is the stronger overall head-to-head candidate over Crescent Capital BDC, Inc. (CCAP) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). GLAD carries a Unified Composite Score of 30.4/100 (SELL) at $17.03 (8.6x Forward P/E, 73.4% operating margin), whereas CCAP carries 27.7/100 (SELL) at $9.80 (6.8x Forward P/E, 77.7% operating margin).
Defensive Composite Rating Caution: Although GLAD compares more favorably head-to-head, both GLAD (30.4/100 SELL) and CCAP (27.7/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
Technical & Structure Timing Caution: GLAD is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 25.3); meanwhile CCAP trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 54.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on GLAD vs CCAP. Trailing 12-month operating profitability (GLAD 73.4% vs CCAP 77.7%) and valuation multiples (GLAD 8.6x vs CCAP 6.8x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Asset Management value chain with $386.8M market capitalization and 73.4% operating margin.
OpEx & R&D Reinvestment26.6% of Rev ($26M)
90D Engineering Disclosures0 Published
CCAP Moat ProfileHigh-Margin Pricing Power Moat
Asset Management Operator
Competes within the Asset Management value chain with $367.4M market capitalization and 77.7% operating margin.
OpEx & R&D Reinvestment22.3% of Rev ($34M)
90D Engineering Disclosures0 Published
Investor FAQ GLAD vs CCAP Key Questions & Quantitative Answers
As of Nov 20, 2026, Gladstone Capital Corp (GLAD) is the stronger overall head-to-head candidate over Crescent Capital BDC, Inc. (CCAP) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). GLAD carries a Unified Composite Score of 30.4/100 (SELL) at $17.03 (8.6x Forward P/E, 73.4% operating margin), whereas CCAP carries 27.7/100 (SELL) at $9.80 (6.8x Forward P/E, 77.7% operating margin). Defensive Composite Rating Caution: Although GLAD compares more favorably head-to-head, both GLAD (30.4/100 SELL) and CCAP (27.7/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: GLAD is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 25.3); meanwhile CCAP trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 54.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
GLAD leads the Growth & Scale pillar: GLAD posts +2.7% YoY revenue growth and +68.8% YoY earnings growth on $100M TTM revenue (100.0% gross margin, 73.4% operating margin), compared with CCAP at -10.8% YoY revenue growth and +40.9% YoY earnings growth on $152M TTM revenue (100.0% gross margin, 77.7% operating margin). On trailing 12-month operating scale, GLAD generates $100M in USD-normalized revenue versus $152M for CCAP. In operating R&D and SG&A reinvestment, GLAD deploys 26.6% of Rev ($26M) (0 90-day corporate R&D disclosures) versus 22.3% of Rev ($34M) (0 disclosures) for CCAP.
CCAP screens cheaper on headline valuation multiples. GLAD trades at 8.6x Forward P/E, 12.1x Trailing P/E, 2.31x PEG, and 3.9x EV/Revenue (unreported cash flow margin), whereas CCAP trades at 6.8x Forward P/E, 6.8x Trailing P/E, 0.89x PEG, and 2.4x EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against GLAD (6.3% ROE) versus CCAP (-0.0% ROE) capital efficiency.
In options market volatility and institutional positioning, GLAD carries 25.7% implied volatility (17th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.53β · 30% Vol realized risk). By comparison, CCAP carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.43β · 48% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.